These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3105531)

  • 1. L-threo-3,4-dihydroxyphenylserine (DOPS) aldolase: a new enzyme cleaving DOPS into protocatechualdehyde and glycine.
    Naoi M; Takahashi T; Kuno N; Nagatsu T
    Biochem Biophys Res Commun; 1987 Mar; 143(2):482-8. PubMed ID: 3105531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS) with thermostabilized low-specific L-threonine aldolase from Streptomyces coelicolor A3(2).
    Balk SH; Yoshioka H; Yukawa H; Harayama S
    J Microbiol Biotechnol; 2007 May; 17(5):721-7. PubMed ID: 18051291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymatic decarboxylation of L-threo-3,4-dihydroxyphenylserine in rat heart.
    Ohmura I; Inagaki C; Araki H; Tanaka C
    Jpn J Pharmacol; 1978 Oct; 28(5):747-53. PubMed ID: 31501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced synthesis of L-threo-3,4-dihydroxyphenylserine by high-density whole-cell biocatalyst of recombinant L-threonine aldolase from Streptomyces avelmitilis.
    Baik SH; Yoshioka H
    Biotechnol Lett; 2009 Mar; 31(3):443-8. PubMed ID: 19039530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Synthesis of norepinephrine from 3,4-dihydroxyphenylserine by L-aromatic amino acid decarboxylase of the rat brain and kidneys].
    Fujiwara H; Inagaki C; Ikeda Y; Tanaka C
    Nihon Yakurigaku Zasshi; 1976 Oct; 72(7):891-8. PubMed ID: 14060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal production of L-threo-2,3-dihydroxyphenylserine (L-threo-DOPS) on a large scale by diastereoselectivity-enhanced variant of L-threonine aldolase expressed in Escherichia coli.
    Gwon HJ; Yoshioka H; Song NE; Kim JH; Song YR; Jeong DY; Baik SH
    Prep Biochem Biotechnol; 2012; 42(2):143-54. PubMed ID: 22394063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake of L-threo-dihydroxyphenylserine into human brain synaptosomes.
    Naoi M; Nagatsu T
    J Neural Transm; 1987; 70(1-2):51-61. PubMed ID: 3117973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new metabolic pathway of L-threo-3,4-dihydroxyphenylserine, a precursor amino acid of norepinephrine, in the brain. Studies by in vivo microdialysis.
    Maruyama W; Nakahara D; Naoi M
    J Neural Transm Park Dis Dement Sect; 1994; 7(1):21-33. PubMed ID: 8579767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of monoamine oxidase by 3,4-dihydroxyphenylserine.
    Naoi M; Nagatsu T
    J Neurochem; 1986 Aug; 47(2):604-7. PubMed ID: 3090204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic studies of oral L-threo-3,4-dihydroxyphenylserine in normal subjects and patients with familial amyloid polyneuropathy.
    Suzuki T; Higa S; Sakoda S; Ueji M; Hayashi A; Takaba Y; Nakajima A
    Eur J Clin Pharmacol; 1982; 23(5):463-8. PubMed ID: 6818040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of an inducible phenylserine aldolase from Pseudomonas putida 24-1.
    Misono H; Maeda H; Tuda K; Ueshima S; Miyazaki N; Nagata S
    Appl Environ Microbiol; 2005 Aug; 71(8):4602-9. PubMed ID: 16085854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of parkinsonism with L-threo-3,4-dihydroxyphenylserine: a pharmacokinetic study.
    Suzuki T; Sakoda S; Ueji M; Kishimoto S; Hayashi A; Kondo T; Narabayashi H
    Neurology; 1984 Nov; 34(11):1446-50. PubMed ID: 6436731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibition of harmaline induced tremor by L-threo-3, 4-dihydroxyphenylserine, an L-norepinephrine precursor].
    Yamazaki M; Ikeda Y; Ishikawa M; Inagaki C; Tanaka C
    Nihon Yakurigaku Zasshi; 1976 Apr; 72(3):363-9. PubMed ID: 986992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of D-threonine aldolase, a pyridoxal-5'-phosphate-dependent enzyme from Arthrobacter sp. DK-38.
    Kataoka M; Ikemi M; Morikawa T; Miyoshi T; Nishi K; Wada M; Yamada H; Shimizu S
    Eur J Biochem; 1997 Sep; 248(2):385-93. PubMed ID: 9346293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the activity of L-threo-3,4-dihydroxyphenylserine (L-DOPS) as a catecholamine precursor in the brain. Comparison with that of L-dopa.
    Kato T; Karai N; Katsuyama M; Nakamura M; Katsube J
    Biochem Pharmacol; 1987 Sep; 36(18):3051-7. PubMed ID: 3115271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective treatment of pure akinesia with L-threo-3,4-dihydroxyphenylserine (DOPS): report of a case, with pharmacological considerations.
    Yamamoto M; Ujike H; Ogawa N
    Clin Neuropharmacol; 1985; 8(4):334-42. PubMed ID: 2416437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DL-threo-DOPS as a precursor of noradrenaline.
    Reches A; Jackson-Lewis V; Fahn S
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):202-8. PubMed ID: 3937060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diastereoselective synthesis of L: -threo-3,4-dihydroxyphenylserine by low-specific L: -threonine aldolase mutants.
    Gwon HJ; Baik SH
    Biotechnol Lett; 2010 Jan; 32(1):143-9. PubMed ID: 19760118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The stereoisomers of 3,4-dihydroxyphenylserine as precursors of norepinephrine.
    Bartholini J; Constantinidis J; Puig M; Tissot R; Pletscher A
    J Pharmacol Exp Ther; 1975 May; 193(2):523-32. PubMed ID: 1142103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of L-threo-3,4-dihydroxyphenylserine on efflux of monoamines and acetylcholine in guinea pig brain.
    Nishino N; Fujii Y; Kondo M; Shuntoh H; Fujiwara H; Tanaka C
    J Pharmacol Exp Ther; 1987 Aug; 242(2):621-8. PubMed ID: 3112367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.